Home/Filings/4/0001062993-23-022200
4//SEC Filing

Shankar Gopi 4

Accession 0001062993-23-022200

CIK 0001374690other

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 4:08 PM ET

Size

5.1 KB

Accession

0001062993-23-022200

Insider Transaction Report

Form 4
Period: 2023-12-07
Shankar Gopi
Chief Development Officer
Transactions
  • Purchase

    Common Stock

    2023-12-07$3.73/sh+5,000$18,6625,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.73 to $3.768, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.

Issuer

Larimar Therapeutics, Inc.

CIK 0001374690

Entity typeother

Related Parties

1
  • filerCIK 0001965014

Filing Metadata

Form type
4
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 4:08 PM ET
Size
5.1 KB